Back to Results

Mustgrow Biologics Corp (MGROF)

MustGrow Biologics Corp. is an agricultural biotechnology company listed on OTC Markets as common stock. The company develops and commercializes natural biological technologies and products derived from mustard plants. Its Biocontrol technology platform is designed for applications such as soil-borne disease and pest control across crops including fruits and vegetables, as well as weed suppression for organic agriculture, home and garden uses, and farming markets where glyphosate is no longer permitted. The platform is also used for sprout suppression and for disease and pathogen control in storage and food preservation settings. MustGrow also markets TerraMG, a mustard-derived soil biopesticide technology, and is developing TerraSante, an organic soil amendment and biofertility product. In addition, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliar products. The company was incorporated in 2014 and is headquartered in Saskatoon, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-MGRO.F
$0.35
15.4% Upside
Fair
Not available
Not available
Fair
0.0%
December 1, 2026
6.1x
3.3x
22.035 M
19.133 M
1.7%
89.3%
-10.1
52.7%
Valuation • Fair Value

Mustgrow Biologics Corp (OTC-MGRO.F) Fair Value by Valuation Model

Review the available estimates for Mustgrow Biologics Corp (OTC-MGRO.F), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.35

Estimated upside of 15.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.32

Discounted cash flow valuation reference.

Comps Fair Value

$0.35

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Mustgrow Biologics Corp (OTC-MGRO.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Mustgrow Biologics Corp (OTC-MGRO.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.705 M

Current operating scale indicator.

Revenue Forecast

3.199 M

Forward revenue estimate.

EBITDA

-3.011 M

Current operating profitability reference.

EBITDA Forecast

-3.093 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Mustgrow Biologics Corp (OTC-MGRO.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Mustgrow Biologics Corp (OTC-MGRO.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

5.33

Higher caution zone on this screen.

Altman Z-Score

-10.1

Lower score that deserves closer risk review.

FCF / Net Income

52.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Mustgrow Biologics Corp (OTC-MGRO.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Mustgrow Biologics Corp (OTC-MGRO.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 1, 2026

Days to Earnings

70

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Mustgrow Biologics Corp (OTC-MGRO.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Mustgrow Biologics Corp (OTC-MGRO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Mustgrow Biologics Corp (OTC-MGRO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Mustgrow Biologics Corp (OTC-MGRO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Mustgrow Biologics Corp (OTC-MGRO.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Mustgrow Biologics Corp (OTC-MGRO.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Mustgrow Biologics Corp (OTC-MGRO.F) Stock FAQ

Data-supported answers about Mustgrow Biologics Corp (OTC-MGRO.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.35
Estimated upside 15.4%
Valuation Rating
Undervalued
Estimated upside of 15.4%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Mustgrow Biologics Corp (OTC-MGRO.F) is $0.35. This implies an estimated upside of 15.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 15.4% versus the current market price.

The current financial health read for Mustgrow Biologics Corp (OTC-MGRO.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Mustgrow Biologics Corp (OTC-MGRO.F) is December 1, 2026.

The latest available data indicates no current dividend yield for Mustgrow Biologics Corp (OTC-MGRO.F).

The current market capitalization listed for Mustgrow Biologics Corp is 22.035 M.

The current enterprise value listed for Mustgrow Biologics Corp is 19.133 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Mustgrow Biologics Corp is OTC-MGRO.F, and the stock is listed on OTC Markets.

Mustgrow Biologics Corp (OTC-MGRO.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Mustgrow Biologics Corp is 1.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Mustgrow Biologics Corp is 89.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Chemicals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LIN NASDAQ Linde PLC Fair Value Fair Market Cap 214.3 B
SHW NYSE Sherwin-Williams Co Fair Value Fair Market Cap 79.241 B
ECL NYSE Ecolab Inc Fair Value Fair Market Cap 77.432 B
APD NYSE Air Products and Chemicals Inc Fair Value Fair Market Cap 64.102 B
CTVA NYSE Corteva Inc Fair Value Fair Market Cap 53.603 B
NTR NYSE Nutrien Ltd Fair Value Fair Market Cap 36.041 B
PPG NYSE PPG Industries Inc Fair Value Fair Market Cap 23.957 B
IFF NYSE International Flavors & Fragrances Inc Fair Value Fair Market Cap 21.889 B
DOW NYSE Dow Inc Fair Value Fair Market Cap 20.37 B
SQM NYSE Sociedad Quimica y Minera de Chile SA ADR B Fair Value Undervalued Market Cap 20.049 B
LYB NYSE LyondellBasell Industries NV Fair Value Undervalued Market Cap 19.137 B
CF NYSE CF Industries Holdings Inc Fair Value Fair Market Cap 18.25 B
DD NYSE Dupont De Nemours Inc Fair Value Fair Market Cap 17.799 B
ALB NYSE Albemarle Corp Fair Value Undervalued Market Cap 13.783 B
RPM NYSE RPM International Inc Fair Value Fair Market Cap 12.906 B
SOLS NASDAQ Solstice Advanced Materials Inc Fair Value Fair Market Cap 9.355 B
WLK NYSE Westlake Chemical Corporation Fair Value Fair Market Cap 8.792 B
SSL NYSE Sasol Ltd Fair Value Undervalued Market Cap 8.644 B
ESI NYSE Element Solutions Inc Fair Value Overvalued Market Cap 8.575 B
NEU NYSE NewMarket Corporation Fair Value Fair Market Cap 8.174 B